UBS Upgrades Nuveen Churchill Direct to Buy, Lowers Price Target to $13

Benzinga Newsdesk www.benzinga.com Negative 83.4%

Neg 83.4% Neu 0% Pos 0%

UBS analyst Melissa Wedel upgrades Nuveen Churchill Direct (NYSE:NCDL) from Neutral to Buy and lowers the price target from $14.75 to $13.